Respiratory News and Research

RSS

Covidien acquires Oridion Systems

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today said that it has completed the previously announced acquisition of Oridion Systems Ltd. for an aggregate consideration of approximately $310 million, net of cash and investments acquired.

26 Jun 2012

Majority of rhinovirus infections are asymptomatic

Asymptomatic human rhinovirus infections outnumber symptomatic infections by a factor of four to one, Canadian researchers report.

26 Jun 2012

Telemedicine could reduce admission rates

Patients with diabetes, heart failure, or chronic obstructive pulmonary disease have fewer emergency hospital admissions when receiving a telehealth intervention than their counterparts who receive usual care, say UK researchers.

26 Jun 2012

“Swine flu” deaths may be fifteen times higher than previously reported

The number of deaths from the 2009 H1N1 (“swine flu”) pandemic may be fifteen times higher than the number of laboratory-confirmed deaths previously reported by countries to the World Health Organization (WHO), according to an Article published Online First in The Lancet Infectious Diseases. While estimates of 2009 H1N1-associated deaths have been derived for some countries such as the United States, these are the first estimates of the worldwide number of deaths caused by the pandemic.

26 Jun 2012

New system provides comprehensive remote monitoring solution for the chronically ill

As Europe's population ages, chronic diseases are becoming increasingly widespread. Characterised by gradually deteriorating health and recurring incidents often requiring immediate medical attention, chronic illnesses have a severe impact on patients' autonomy and life quality and are putting increasing strain on over-stretched healthcare systems.

26 Jun 2012

‘Strong evidence’ for causal link between parental smoking, childhood asthma

Parental smoking is associated with symptoms of asthma in exposed children, report researchers who found the more parents smoked, the greater the risk to their children.

25 Jun 2012

NIH awards Sirnaomics SBIR grant for developing STP705 siRNA wound healing product

Sirnaomics, Inc. announced today that the company has been awarded another NIH SBIR grant for developing its small interfering RNA (siRNA) therapeutic product STP705 to improve skin wound healing with minimized scar formation.

25 Jun 2012

iWorx launches IX-100BE Data Acquisition System with LabScribe2 Software

iWorx, a developer of advanced physiology research tools, has introduced the IX-100BE Data Acquisition System with LabScribe2 Software that provides high resolution/low noise recording of biopotential signals for OEM applications.

25 Jun 2012

U.S. District Court rules in favor of Teva in COPAXONE patent infringement case

Teva Pharmaceutical Industries Ltd. announced today the U.S. District Court for the Southern District of New York has found in favor of Teva in the Company's patent infringement lawsuit against Momenta Pharmaceuticals, Inc./Sandoz Inc. and Mylan Laboratories Inc./Natco Pharmaceuticals regarding Teva's relapsing-remitting multiple sclerosis (RRMS) product, COPAXONE.

23 Jun 2012

EMA CHMP adopts positive opinion for Seebri Breezhaler to treat COPD

Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

23 Jun 2012

Structured exercise programmes benefit lung transplant patients

Lung transplant patients who took part in a three-month structured exercise program when they were discharged from hospital improved their health-related quality of life and reduced their risk of cardiovascular problems.

22 Jun 2012

Teva launches Olanzapine and Fluoxetine Capsules for treatment of depression

Teva Pharmaceutical Industries Ltd. announced today the launch of Olanzapine and Fluoxetine Capsules USP 6 mg/25 mg, 12 mg/25 mg, 6 mg/50 mg, and 12 mg/50 mg, the Company's generic equivalent of Symbyax.

22 Jun 2012

Genetics play a significant role in determining side effects of opiates

Genetics play a significant role in determining which patients will suffer the most from the disturbing side effects of opiates, commonly prescribed painkillers for severe to moderate pain, according to a new Stanford University School of Medicine study, which pinpoints nausea, slowed breathing and potential for addiction as heritable traits.

21 Jun 2012

Two-thirds of children think parents do almost no physical activity

Children who said their parents do almost no physical activity have a 50 per cent greater risk of being unfit than children with more physically active parents, according to new research.

21 Jun 2012

$Study tests link between anesthesia type, complications and mortality after hip fracture surgery$

Study tests link between anesthesia type, complications and mortality after hip fracture surgery

Anesthesia type may affect complications and mortality after hip fracture surgery, according to a new study in the July issue of Anesthesiology. The Perelman School of Medicine at the University of Pennsylvania study tested the association between regional versus general anesthesia, and pulmonary and cardiovascular complications and mortality.

21 Jun 2012

International Consensus on Pediatric Asthma launches in Geneva

The International Consensus (ICON) on Pediatric Asthma has been launched during the EAACI Congress 2012 in Geneva. The goal of this ICON is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on their differences, thus providing a concise reference. The Pediatric Asthma ICON provides advice for the best clinical practice in pediatric asthma management.

21 Jun 2012

Study links two specific strains of bacteria with indoor mold from water damage

Bacterial contamination in water-damaged buildings has been identified as a potential cause of health problems, including infection and respiratory conditions like asthma. Which specific bacteria contribute to these problems, however, has been unknown-making it difficult for public health officials to develop tools to effectively address the underlying source of the problem.

21 Jun 2012

ECC calls on policy makers across Europe to reduce burden of COPD

As leading figures in respiratory health from across the globe gather in Birmingham for the COPD8 conference ahead of World Spirometry Day, the European COPD Coalition (ECC) is calling on policy makers across Europe to recognise that chronic diseases such as COPD, present as great a threat as the global financial crisis, and is urging collective action.

20 Jun 2012

FDA provides Orphan Drug Designation to Alnylam’s ALN-TTR02

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. Food & Drug Administration (FDA) has provided Orphan Drug Designation to ALN-TTR02 as a therapeutic for the treatment of familial amyloidotic polyneuropathy (FAP), one of the predominant clinical manifestations of transthyretin (TTR)-mediated amyloidosis (ATTR).

20 Jun 2012

GenMark intends to commence underwritten public offering of common stock

GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that it intends to commence an underwritten public offering of 10,000,000 shares of its common stock. All of the shares in the proposed offering are to be sold by GenMark.

20 Jun 2012